Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-25-021050

CEO and President bought 675,675 shares at $0.37 ($250,000)

  • CEO and President gave up 3,104 shares (to pay taxes)
  • CEO and President acquired 12,740 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KLEMP WALTER V · CEO and President

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-20 Exercise or conversion : show line 1 in the form +3,750 62,046 D
2025-06-20 Shares withheld for taxes : show line 2 in the form −914 $0.27 $244 61,132 D
2025-06-22 Exercise or conversion : show line 3 in the form +8,990 70,122 D
2025-06-22 Shares withheld for taxes : show line 4 in the form −2,190 $0.27 $585 67,932 D
2025-06-23 Purchase : show line 5 in the form +675,675 $0.37 $250,000 743,607 D
Open-market purchases · 675,675 sh · avg $0.37 · $250,000

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2025-06-20 Exercise or conversion : show line 6 in the form Restricted Stock Units −3,750 391,446 D
2025-06-22 Exercise or conversion : show line 7 in the form Restricted Stock Units −8,990 382,456 D
2025-06-23 Purchase : show line 8 in the form Series E Warrants −2,027,025 2,409,481 D
Loading xslF345X05/rdgdoc.xml…